Target intelligence / Profile preview

RNA G-quadruplex (rG4) (rG4)

Target
rG4
Molecular classification
Non-canonical nucleic acid structure, RNA
01

Overview

RNA G-quadruplexes (rG4s) are highly stable, non-canonical secondary structures formed by guanine-rich RNA sequences through Hoogsteen base pairing. These structures are widely distributed across the human transcriptome, particularly within the 5' untranslated regions (UTRs) of mRNAs, where they typically function as steric hurdles that repress translation (Kwok et al., 2017, Trends Biochem Sci). Beyond translation, rG4s play critical roles in regulating alternative splicing, mRNA localization, and the stability of long non-coding RNAs (Fay et al., 2017, J Biol Chem). In oncology, rG4s are often found in the transcripts of key proto-oncogenes, making them attractive targets for small-molecule stabilization to downregulate protein expression (Balasubramanian et al., 2011, Nat Rev Drug Discov). Additionally, expanded G-rich repeats in neurodegenerative diseases, such as those in the C9orf72 gene, form toxic rG4 structures that contribute to disease pathogenesis (Haeusler et al., 2014, Nature). Therapeutic strategies focus on using ligands to stabilize these structures to modulate gene expression or prevent toxic protein aggregation. Recent research also highlights the role of rG4s in viral genomes, such as HIV-1 and SARS-CoV-2, where they regulate viral replication and assembly (Wang et al., 2021, Nucleic Acids Res).

Other names
G-quadruplex-forming RNArG4RNA G4G4-RNA
02

Mechanism of action

Small molecule stabilization of rG4 structures to inhibit ribosomal scanning and translation, or to disrupt RNA-protein interactions.

03

Biological functions

Translation regulationmRNA stability controlSplicing regulationTelomere maintenanceViral genome replication
04

Disease associations

CancerNeurodegenerative diseaseViral infectionAmyotrophic lateral sclerosis (ALS)Frontotemporal dementia (FTD)
05

Safety considerations

Off-target binding to DNA G-quadruplexesSystemic toxicity due to ubiquitous nature of G-rich sequencesInterference with essential RNA processing
06

Interacting drugs

CX-5461

4 more in the full profile.

07

Biomarkers

rG4-seq enrichmentBG4 antibody reactivityG4RP-seq signatures

Beyond the preview

Go deeper on RNA G-quadruplex (rG4) (rG4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA G-quadruplex (rG4) (rG4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call